$AMRX
Amneal Pharmaceuticals, Inc.

2024 Q2 Form 10-Q Financial Statement

#000172312824000021 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $701.8M $659.2M
YoY Change 17.15% 18.23%
Cost Of Revenue $451.8M $421.1M
YoY Change 19.21% 11.01%
Gross Profit $249.9M $238.1M
YoY Change 13.6% 33.6%
Gross Profit Margin 35.62% 36.11%
Selling, General & Admin $116.5M $112.6M
YoY Change 10.32% 10.28%
% of Gross Profit 46.59% 47.3%
Research & Development $36.05M $39.30M
YoY Change -4.62% 1.57%
% of Gross Profit 14.42% 16.51%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $152.5M $151.9M
YoY Change 6.38% 7.89%
Operating Profit $95.47M -$10.75M
YoY Change 19.21% -131.19%
Interest Expense -$65.72M -$65.70M
YoY Change 29.22% 33.23%
% of Operating Profit -68.84%
Other Income/Expense, Net -$75.07M -$64.78M
YoY Change 48.87% 47.64%
Pretax Income $20.41M -$75.52M
YoY Change -31.2% 701.21%
Income Tax $3.600M $6.200M
% Of Pretax Income 17.64%
Net Earnings $5.994M -$91.64M
YoY Change -73.04% 486.29%
Net Earnings / Revenue 0.85% -13.9%
Basic Earnings Per Share $0.02 -$0.30
Diluted Earnings Per Share $0.02 -$0.30
COMMON SHARES
Basic Shares Outstanding 308.7M shares 307.0M shares
Diluted Shares Outstanding 319.0M shares 307.3M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $43.77M $46.52M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $575.6M $570.7M
Prepaid Expenses
Receivables
Other Receivables $7.885M $12.80M
Total Short-Term Assets $1.485B $1.380B
YoY Change 4.48% 5.56%
LONG-TERM ASSETS
Property, Plant & Equipment $425.4M $439.8M
YoY Change -7.35% -4.93%
Goodwill $598.5M $598.5M
YoY Change -0.11% -0.1%
Intangibles $819.9M $859.3M
YoY Change -19.25% -18.58%
Long-Term Investments
YoY Change
Other Assets $77.03M $73.75M
YoY Change -17.39% -14.67%
Total Long-Term Assets $2.024B $2.076B
YoY Change -11.17% -10.47%
TOTAL ASSETS
Total Short-Term Assets $1.485B $1.380B
Total Long-Term Assets $2.024B $2.076B
Total Assets $3.510B $3.456B
YoY Change -5.16% -4.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $199.6M $175.3M
YoY Change 43.04% 28.05%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $225.2M $33.66M
YoY Change 640.52% 12.33%
Total Short-Term Liabilities $1.114B $834.4M
YoY Change 43.35% 18.57%
LONG-TERM LIABILITIES
Long-Term Debt $2.178B $2.378B
YoY Change -14.58% -7.18%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $2.400B $2.639B
YoY Change -12.44% -4.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.114B $834.4M
Total Long-Term Liabilities $2.400B $2.639B
Total Liabilities $3.514B $3.473B
YoY Change -0.11% 0.25%
SHAREHOLDERS EQUITY
Retained Earnings -$575.8M -$581.8M
YoY Change 43.52% 40.83%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$57.47M -$63.72M
YoY Change
Total Liabilities & Shareholders Equity $3.510B $3.456B
YoY Change -5.16% -4.69%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $5.994M -$91.64M
YoY Change -73.04% 486.29%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$4.410M
YoY Change -103.16%
INVESTING ACTIVITIES
Capital Expenditures $9.198M
YoY Change -5.06%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$19.76M
YoY Change 68.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$23.16M
YoY Change 79.5%
NET CHANGE
Cash From Operating Activities -$4.410M
Cash From Investing Activities -$19.76M
Cash From Financing Activities -$23.16M
Net Change In Cash -$47.49M
YoY Change -141.0%
FREE CASH FLOW
Cash From Operating Activities -$4.410M
Capital Expenditures $9.198M
Free Cash Flow -$13.61M
YoY Change -110.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
421131000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
379354000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
238060000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
178186000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
112595000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
102096000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39298000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38690000 usd
CY2024Q1 us-gaap Royalty Expense
RoyaltyExpense
984000 usd
CY2023Q1 us-gaap Royalty Expense
RoyaltyExpense
1644000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
1470000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
510000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-100000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-2457000 usd
CY2024Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-94359000 usd
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1224000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10746000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
34449000 usd
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-65703000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-49315000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1197000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1901000 usd
CY2024Q1 amrx Increase Decrease In Tax Receivable Agreement Liability
IncreaseDecreaseInTaxReceivableAgreementLiability
-1948000 usd
CY2023Q1 amrx Increase Decrease In Tax Receivable Agreement Liability
IncreaseDecreaseInTaxReceivableAgreementLiability
-826000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4072000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4365000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-64776000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-43875000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-75522000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9426000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6156000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
668000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-81678000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-10094000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9965000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3151000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-91643000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6943000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
307279000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152109000 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-81678000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-10094000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9965000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3151000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-91643000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6943000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-390000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1797000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
15543000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-14270000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
6515000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-6236000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
8638000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6237000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-83005000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13180000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46520000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91542000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
5097000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7565000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
570653000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
581384000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
87298000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
82685000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1380044000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1377863000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
439815000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
447574000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
598549000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
598629000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
859272000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
890423000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
73747000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
55517000 usd
CY2024Q1 us-gaap Assets
Assets
3456397000 usd
CY2023Q4 us-gaap Assets
Assets
3472569000 usd
CY2024Q1 us-gaap Litigation Reserve Current
LitigationReserveCurrent
30130000 usd
CY2023Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
76988000 usd
CY2024Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
179000000 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
179000000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
33660000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
34125000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
834388000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
846595000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2377707000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2386004000 usd
CY2024Q1 us-gaap Other Notes Payable
OtherNotesPayable
41893000 usd
CY2023Q4 us-gaap Other Notes Payable
OtherNotesPayable
41447000 usd
CY2024Q1 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
85479000 usd
CY2023Q4 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
316000 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2638616000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2564670000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
47022000 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
41293000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
538720000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
539240000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-581819000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-490176000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23711000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-32349000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-63724000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
19781000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
95000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
230000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-63629000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20011000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3456397000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3472569000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-81678000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-10094000 usd
CY2024Q1 amrx Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts
55528000 usd
CY2023Q1 amrx Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts
58150000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1511000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1987000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
288000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2058000 usd
CY2024Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
920000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
100000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2457000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6722000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7596000 usd
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
22923000 usd
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
25204000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1250000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2047000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
55173000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-195970000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12200000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
22508000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11708000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-29160000 usd
CY2024Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
562000 usd
CY2023Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-470000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
62174000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-150483000 usd
CY2024Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
5495000 usd
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
1672000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4410000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
139712000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9198000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9688000 usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9700000 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
338000 usd
CY2024Q1 amrx Payments To Acquire Property Plant And Equipment Deposits
PaymentsToAcquirePropertyPlantAndEquipmentDeposits
862000 usd
CY2023Q1 amrx Payments To Acquire Property Plant And Equipment Deposits
PaymentsToAcquirePropertyPlantAndEquipmentDeposits
1711000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19760000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11737000 usd
CY2023Q1 amrx Repayments Of Long Term Debt Revolving Credit Facility And Financing Lease Obligations
RepaymentsOfLongTermDebtRevolvingCreditFacilityAndFinancingLeaseObligations
72659000 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
48000000 usd
CY2024Q1 amrx Repayments Of Long Term Debt Revolving Credit Facility And Financing Lease Obligations
RepaymentsOfLongTermDebtRevolvingCreditFacilityAndFinancingLeaseObligations
63377000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
80000000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
28000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7212000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2022000 usd
CY2024Q1 amrx Tax Distribution To Noncontrolling Interest Financing Activities
TaxDistributionToNoncontrollingInterestFinancingActivities
594000 usd
CY2023Q1 amrx Tax Distribution To Noncontrolling Interest Financing Activities
TaxDistributionToNoncontrollingInterestFinancingActivities
18219000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23155000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12900000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-165000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
767000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-47490000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
115842000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99107000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35227000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51617000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151069000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46520000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
144674000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
5097000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
6395000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51617000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151069000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
64514000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
41066000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-4567000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3421000 usd
CY2024Q1 amrx Noncash Or Part Noncash Acquisition Tax Distributions To Noncontrolling Interests
NoncashOrPartNoncashAcquisitionTaxDistributionsToNoncontrollingInterests
3777000 usd
CY2023Q1 amrx Noncash Or Part Noncash Acquisition Tax Distributions To Noncontrolling Interests
NoncashOrPartNoncashAcquisitionTaxDistributionsToNoncontrollingInterests
11548000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20011000 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
41293000 usd
CY2024Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-91778000 usd
CY2024Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
10100000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-390000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6722000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
28000 usd
CY2024Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-7250000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
15543000 usd
CY2024Q1 amrx Temporary Equity Tax Distribution
TemporaryEquityTaxDistribution
4371000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
6515000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-63629000 usd
CY2024Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
47022000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
183979000 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
24949000 usd
CY2023Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-15631000 usd
CY2023Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
5537000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1797000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7596000 usd
CY2023Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1995000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-14270000 usd
CY2023Q1 amrx Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders Tax Distribution
NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersTaxDistribution
26808000 usd
CY2023Q1 amrx Temporary Equity Tax Distribution
TemporaryEquityTaxDistribution
2959000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
134668000 usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
27527000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:106%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements requires the Company's management to make estimates and assumptions that affect the reported financial position at the date of the financial statements and the reported results of operations during the reporting period. Such estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The following are some, but not all, of such estimates: the determination of chargebacks, sales returns, rebates, valuation of intangible and other assets acquired in business combinations, allowances for accounts receivable, accrued liabilities, liabilities for legal matters, contingent liabilities, initial and subsequent valuation of contingent consideration recognized in business combinations, stock-based compensation, valuation of inventory balances, the determination of useful lives for product rights and the assessment of expected cash flows used in evaluating goodwill and other long-lived assets for impairment. Actual results could differ from those estimates.</span></div>
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The prior period balance related to the TRA (as defined in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 5. Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) of $0.8 million, formerly included in other income, net for the three months ended March 31, 2023, has been reclassified to the income statement caption “increase in tax receivable agreement liability” to conform to the current period presentation in the consolidated statements of operations. This reclassification did not impact total other expense, net or net loss.</span></div>The prior period balance related to long-term liabilities for legal matters of $0.3 million, formerly included in other long-term liabilities as of December 31, 2023, has been reclassified to the balance sheet caption “liabilities for legal matters - long term” to conform to the current period presentation in the consolidated balance sheets. This reclassification did not impact total long-term liabilities or total liabilities
CY2023Q1 amrx Increase Decrease In Tax Receivable Agreement Liability
IncreaseDecreaseInTaxReceivableAgreementLiability
-800000 usd
CY2023Q4 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
300000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
659191000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
557540000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6200000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.082
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.071
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
566000000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
566500000 usd
CY2018 amrx Tax Receivable Agreement Payment Ratio
TaxReceivableAgreementPaymentRatio
0.01
CY2018 amrx Percentage Of Tax Benefits Under Tax Receivable Agreement
PercentageOfTaxBenefitsUnderTaxReceivableAgreement
0.85
CY2019 amrx Reversal Of Accrued Tax Receivable Agreement Liability
ReversalOfAccruedTaxReceivableAgreementLiability
192800000 usd
amrx Percentage Of Tax Benefits Under Tax Receivable Agreement
PercentageOfTaxBenefitsUnderTaxReceivableAgreement
0.85
CY2023Q4 amrx Percentage Of Tax Benefits Under Tax Receivable Agreement
PercentageOfTaxBenefitsUnderTaxReceivableAgreement
0.75
CY2024Q1 amrx Liabilities Under Tax Receivable Agreement Noncurrent
LiabilitiesUnderTaxReceivableAgreementNoncurrent
185000000 usd
CY2023Q4 amrx Liabilities Under Tax Receivable Agreement Noncurrent
LiabilitiesUnderTaxReceivableAgreementNoncurrent
185000000 usd
CY2024Q1 amrx Tax Receivable Agreement Liability
TaxReceivableAgreementLiability
5700000 usd
CY2023Q4 amrx Tax Receivable Agreement Liability
TaxReceivableAgreementLiability
3800000 usd
CY2024Q1 amrx Increase Decrease In Tax Receivable Agreement Liability
IncreaseDecreaseInTaxReceivableAgreementLiability
-1900000 usd
CY2023Q1 amrx Increase Decrease In Tax Receivable Agreement Liability
IncreaseDecreaseInTaxReceivableAgreementLiability
-800000 usd
CY2024Q1 amrx Tax Receivable Agreement Liability
TaxReceivableAgreementLiability
5700000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-91643000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6943000 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
307279000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
307279000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152109000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152109000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1156861000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1199980000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3037000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3022000 usd
CY2024Q1 amrx Contract Charge Backs And Sales Volume Allowances Current
ContractChargeBacksAndSalesVolumeAllowancesCurrent
457454000 usd
CY2023Q4 amrx Contract Charge Backs And Sales Volume Allowances Current
ContractChargeBacksAndSalesVolumeAllowancesCurrent
559334000 usd
CY2024Q1 amrx Cash Discount Allowances Current
CashDiscountAllowancesCurrent
27415000 usd
CY2023Q4 amrx Cash Discount Allowances Current
CashDiscountAllowancesCurrent
23892000 usd
CY2024Q1 amrx Allowance For Accounts Receivable Current
AllowanceForAccountsReceivableCurrent
487906000 usd
CY2023Q4 amrx Allowance For Accounts Receivable Current
AllowanceForAccountsReceivableCurrent
586248000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
196737000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
217744000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
57924000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
59563000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
315992000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
304077000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
570653000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
581384000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1935000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2200000 usd
CY2024Q1 us-gaap Prepaid Insurance
PrepaidInsurance
4780000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
8334000 usd
CY2024Q1 amrx Prepaid Regulatory Fees Current
PrepaidRegulatoryFeesCurrent
4219000 usd
CY2023Q4 amrx Prepaid Regulatory Fees Current
PrepaidRegulatoryFeesCurrent
6331000 usd
CY2024Q1 amrx Income And Other Taxes Receivable
IncomeAndOtherTaxesReceivable
12198000 usd
CY2023Q4 amrx Income And Other Taxes Receivable
IncomeAndOtherTaxesReceivable
13168000 usd
CY2024Q1 us-gaap Prepaid Taxes
PrepaidTaxes
9205000 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
11899000 usd
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
12802000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
9929000 usd
CY2024Q1 amrx Chargebacks Receivable Current
ChargebacksReceivableCurrent
8575000 usd
CY2023Q4 amrx Chargebacks Receivable Current
ChargebacksReceivableCurrent
7876000 usd
CY2024Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
33584000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
22948000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
87298000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
82685000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
598629000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
598853000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-80000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-224000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
598549000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
598629000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1319269000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
815842000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
503427000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1310771000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
776193000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
534578000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
355845000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
355845000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
355845000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
355845000 usd
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1675114000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
815842000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
859272000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1666616000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
776193000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
890423000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
39900000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
41100000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
355800000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
119432000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
121638000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
73115000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
52606000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
33263000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
26484000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
76889000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
503427000 usd
CY2024Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
73747000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
55517000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
33660000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
34125000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2377707000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2386004000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
175325000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
143572000 usd
CY2024Q1 amrx Accrued Sales Returns Allowance Current
AccruedSalesReturnsAllowanceCurrent
137108000 usd
CY2023Q4 amrx Accrued Sales Returns Allowance Current
AccruedSalesReturnsAllowanceCurrent
136486000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
44806000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
71122000 usd
CY2024Q1 amrx Accrued Sales Rebates Current
AccruedSalesRebatesCurrent
96711000 usd
CY2023Q4 amrx Accrued Sales Rebates Current
AccruedSalesRebatesCurrent
90690000 usd
CY2024Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
19779000 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
23342000 usd
CY2024Q1 amrx Rebates And Chargebacks
RebatesAndChargebacks
10226000 usd
CY2023Q4 amrx Rebates And Chargebacks
RebatesAndChargebacks
10226000 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
14598000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
11005000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
59965000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
48219000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2528928000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2543626000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
117561000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
123497000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
2411367000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
2420129000 usd
CY2024Q1 us-gaap Interest Rate Cash Flow Hedge Asset At Fair Value
InterestRateCashFlowHedgeAssetAtFairValue
52632000 usd
CY2024Q1 amrx Deferred Compensation Plan Liabilities Fair Value Disclosures
DeferredCompensationPlanLiabilitiesFairValueDisclosures
9668000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1021000 usd
CY2023Q4 us-gaap Interest Rate Cash Flow Hedge Asset At Fair Value
InterestRateCashFlowHedgeAssetAtFairValue
37089000 usd
CY2023Q4 amrx Deferred Compensation Plan Liabilities Fair Value Disclosures
DeferredCompensationPlanLiabilitiesFairValueDisclosures
9100000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
921000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
6500000 usd
CY2024Q1 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
26100000 usd
CY2024Q1 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
42800000 usd
CY2024Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-94400000 usd
CY2024Q1 us-gaap Litigation Reserve Current
LitigationReserveCurrent
30130000 usd
CY2023Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
76988000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
26800000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 amrx Number Of Products Families
NumberOfProductsFamilies
270 product
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
659191000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
421131000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
238060000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
112595000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39298000 usd
CY2024Q1 us-gaap Royalty Expense
RoyaltyExpense
984000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
1470000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-100000 usd
CY2024Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-94359000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10746000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
557540000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
379354000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
178186000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
102096000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38690000 usd
CY2023Q1 us-gaap Royalty Expense
RoyaltyExpense
1644000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
510000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-2457000 usd
CY2023Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
436000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1224000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
34449000 usd

Files In Submission

Name View Source Status
0001723128-24-000021-index-headers.html Edgar Link pending
0001723128-24-000021-index.html Edgar Link pending
0001723128-24-000021.txt Edgar Link pending
0001723128-24-000021-xbrl.zip Edgar Link pending
amrx-20240331.htm Edgar Link pending
amrx-20240331.xsd Edgar Link pending
amrx-2024033110xqexx311.htm Edgar Link pending
amrx-2024033110xqexx312.htm Edgar Link pending
amrx-2024033110xqexx313.htm Edgar Link pending
amrx-2024033110xqexx321.htm Edgar Link pending
amrx-2024033110xqexx322.htm Edgar Link pending
amrx-2024033110xqexx323.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
amrx-20240331_def.xml Edgar Link unprocessable
amrx-20240331_lab.xml Edgar Link unprocessable
amrx-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
amrx-20240331_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
amrx-20240331_cal.xml Edgar Link unprocessable